MarketPeel
Insider Trading Intelligence
Pricing
…
WL

William J. Phd Link

TARS
DIRECTOR · TARSUS PHARMACEUTICALS, INC. · CIK 0001228684
FILING MIX · LIFETIME58%/42%
BUYS
57
SELLS
41
TOTAL VALUE
$12.50M
COMPANIES
5
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
672,930
AVG SELL PX
$57.14
TRADE KIND
SHOWING 98 / 98
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 23 pending
Forward-return performance of every backtestable P/S trade by William J. Phd Link, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+40.00%-1.39%+0.97%-2.37%-3.59%—
14d15+26.67%+2.19%+0.59%+1.60%+0.81%—
30d15+33.33%+6.03%+3.16%+2.87%-0.41%—
60d15+53.33%+1.21%+4.82%-3.61%-16.18%—
90d15+53.33%+15.90%+4.91%+10.99%-12.67%—
180d15(3 pending)+58.33%+10.44%+10.79%-0.35%-21.11%—
1y15(9 pending)+66.67%+8.46%+23.69%-15.23%-56.59%—
2y15(11 pending)+100.00%-55.47%+29.14%-84.61%-84.61%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARS · 806 shares · as of Jun 25, 2026
0278,075556,151834,2261,112,301202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 57 buys / 41 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
806——806Jun 25, 2026Jun 29, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,837——3,837Jun 25, 2026Jun 29, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,417——2,417Jun 25, 2026Jun 29, 2026 ↗View →
RXST
RXSIGHT, INC.
PURCHASEGRANT
Stock grant
37,037——74,892Jun 17, 2026Jun 18, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
10,572$61.97$655.1K108,714Jun 15, 2026Jun 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,928$62.94$121.3K106,786Jun 15, 2026Jun 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
2,954——0Jun 12, 2026Jun 16, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
2,954——119,286Jun 12, 2026Jun 16, 2026 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
17,421——568,062Jun 3, 2026Jun 5, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
8,378$69.03$578.3K116,825Mar 16, 2026Mar 18, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
493$69.75$34.4K116,332Mar 16, 2026Mar 18, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,629$68.09$247.1K125,203Mar 16, 2026Mar 18, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,306$81.75$515.5K129,980Dec 15, 2025Dec 17, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,148$82.39$94.6K128,832Dec 15, 2025Dec 17, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,766$81.50$388.4K0Dec 15, 2025Dec 17, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,046$80.80$407.7K136,286Dec 15, 2025Dec 17, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,680$80.71$458.4K4,766Dec 15, 2025Dec 17, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALEGRANT
Gift
2,000——141,332Sep 16, 2025Sep 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
27,116$57.00$1.55M143,332Sep 8, 2025Sep 10, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
3,350——170,448Jun 13, 2025Jun 16, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
3,350——0Jun 13, 2025Jun 16, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,540——4,540Jun 12, 2025Jun 16, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,954——2,954Jun 12, 2025Jun 16, 2025 ↗View →
RXST
RXSIGHT, INC.
PURCHASEGRANT
Stock grant
10,752——37,855Jun 3, 2025Jun 4, 2025 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
7,374——550,641May 23, 2025May 28, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
74,892——35,000Aug 12, 2024Aug 14, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
27,116——167,098Aug 12, 2024Aug 14, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
29,979$26.01$779.8K5,021Aug 12, 2024Aug 14, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
5,021$26.53$133.2K0Aug 12, 2024Aug 14, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
10,446——10,446Aug 12, 2024Aug 14, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
3,350——139,982Jun 24, 2024Jun 25, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
3,350——0Jun 24, 2024Jun 25, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Jun 13, 2024Jun 14, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,350——3,350Jun 13, 2024Jun 14, 2024 ↗View →
RXST
RXSIGHT, INC.
PURCHASEGRANT
Stock grant
2,554——27,103Jun 6, 2024Jun 10, 2024 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
22,000——543,267May 7, 2024May 9, 2024 ↗View →
RXST
RXSIGHT, INC.
SALE
20,598$49.54$1.02M31,900Feb 1, 2024Feb 2, 2024 ↗View →
RXST
RXSIGHT, INC.
SALEGRANT
Gift
3,000——21,248Feb 1, 2024Feb 2, 2024 ↗View →
RXST
RXSIGHT, INC.
SALE
7,652$50.01$382.7K24,248Feb 1, 2024Feb 2, 2024 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
2,610——24,549Aug 17, 2023Aug 18, 2023 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
21,248——52,498Aug 17, 2023Aug 18, 2023 ↗View →
RXST
RXSIGHT, INC.
SALE
694,124——0Aug 17, 2023Aug 18, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Jun 22, 2023Jun 26, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,350——3,350Jun 22, 2023Jun 26, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
2,000——0Jun 16, 2023Jun 21, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
2,000——136,632Jun 16, 2023Jun 21, 2023 ↗View →
RXST
RXSIGHT, INC.
PURCHASEGRANT
Stock grant
5,731——21,939Jun 1, 2023Jun 5, 2023 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
33,175——33,175May 25, 2023May 30, 2023 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
9,288——521,267May 25, 2023May 30, 2023 ↗View →
RXST
RXSIGHT, INC.
SALE
258,390——0May 11, 2023May 12, 2023 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
98,715——694,124May 11, 2023May 12, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
41,219——109,892May 11, 2023May 15, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
215,576——0May 11, 2023May 15, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
52,194——68,673Mar 15, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
215,575——215,576Mar 15, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
215,575——431,151Nov 10, 2022Nov 14, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
8,382——16,479Nov 10, 2022Nov 14, 2022 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
107,236——595,409Nov 9, 2022Nov 14, 2022 ↗View →
RXST
RXSIGHT, INC.
SALE
316,694——258,390Nov 9, 2022Nov 14, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
215,575——646,726Aug 15, 2022Aug 17, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
3,749——8,097Aug 15, 2022Aug 17, 2022 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
107,236——488,173Aug 10, 2022Aug 11, 2022 ↗View →
RXST
RXSIGHT, INC.
SALE
316,694——575,084Aug 10, 2022Aug 11, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
7,000——7,000Jun 16, 2022Jul 1, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,000——2,000Jun 16, 2022Jul 1, 2022 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
126,979——380,937Jun 8, 2022Jun 9, 2022 ↗View →
RXST
RXSIGHT, INC.
SALE
375,000——891,778Jun 8, 2022Jun 9, 2022 ↗View →
RXST
RXSIGHT, INC.
PURCHASEGRANT
Stock grant
10,349——47,458Jun 2, 2022Jun 3, 2022 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
4,285——511,979May 25, 2022May 31, 2022 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
15,616——15,616May 25, 2022May 31, 2022 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
126,979——253,958May 17, 2022Jun 8, 2022 ↗View →
RXST
RXSIGHT, INC.
SALE
375,000——1,266,778May 17, 2022May 19, 2022 ↗View →
RXST
RXSIGHT, INC.
SALE
375,000——1,641,778Mar 15, 2022Mar 17, 2022 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
126,979——126,979Mar 15, 2022Jun 8, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
250,000——862,301Nov 11, 2021Nov 16, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
4,348——4,348Nov 11, 2021Nov 16, 2021 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
31,250$16.00$500.0K37,109Aug 3, 2021Aug 5, 2021 ↗View →
RXST
RXSIGHT, INC.
SALE
2,016,778——0Aug 3, 2021Aug 5, 2021 ↗View →
RXST
RXSIGHT, INC.
PURCHASE
2,016,778——2,016,778Aug 3, 2021Aug 5, 2021 ↗View →
RXST
RXSIGHT, INC.
PURCHASEGRANT
Stock grant
5,859——5,859Jul 30, 2021Aug 2, 2021 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 15, 2021Jun 17, 2021 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,382——17,821Jun 3, 2021Jun 7, 2021 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
20,847——20,847May 18, 2021May 20, 2021 ↗View →
LNSR
LENSAR, INC.
PURCHASEGRANT
Stock grant
80,157——507,694Dec 7, 2020Dec 10, 2020 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
25,000$32.00$800.0K50,439Dec 1, 2020Dec 3, 2020 ↗View →
GKOS
GLAUKOS CORP
SALE
10,000——0Dec 1, 2020Dec 3, 2020 ↗View →
GKOS
GLAUKOS CORP
SALE
600$68.72$41.2K15,439Dec 1, 2020Dec 3, 2020 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
10,000$7.28$72.8K25,439Dec 1, 2020Dec 3, 2020 ↗View →
GKOS
GLAUKOS CORP
SALE
25,000——0Dec 1, 2020Dec 3, 2020 ↗View →
GKOS
GLAUKOS CORP
SALE
49,400$67.96$3.36M16,039Dec 1, 2020Dec 3, 2020 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
15,000$24.69$370.4K65,439Dec 1, 2020Dec 3, 2020 ↗View →
GKOS
GLAUKOS CORP
SALE
15,000——0Dec 1, 2020Dec 3, 2020 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
1,112,301——1,112,301Oct 20, 2020Oct 20, 2020 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
1,112,301——0Oct 20, 2020Oct 20, 2020 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
3,900——15,439Jun 3, 2020Jun 5, 2020 ↗View →
EW
EDWARDS LIFESCIENCES CORP
PURCHASEGRANT
Stock grant
1,101——11,004May 8, 2020May 11, 2020 ↗View →
EW
EDWARDS LIFESCIENCES CORP
PURCHASEGRANT
Stock grant
345——11,349May 8, 2020May 11, 2020 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,113——11,539Jan 2, 2020Jan 3, 2020 ↗View →
Other insiders · TARS
Loading peer insiders…
About this filer
CIK 0001228684
ROLE
Director
PRIMARY
TARS
COMPANIES
5
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001228684DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback